Happy Monday study trade treats listeners.

My name is Bryce Toey and Matt,

why don't you say hi?

I feel like it's been a little while.

Yeah, how's it going, everyone?

In and Out is just super busy between like personal stuff.

I sold a full-time job if you're not aware.

So Bryce has been managing the treats episodes the last couple of times.

He's done great, but I'm back

for Monday to kick us off into September. He's not going to promise he's here for the full

week, but we'll find out. It is a holiday weekend. So that is true. Labor Day. That's true.

All right, Matt, so you know, you've been, you've at least been seeing the markets.

Nothing really changed. OTCs have been a little hotter towards the end of the week. I shouldn't say a little hotter. They've been hot, like, sporadically. I still haven't seen a lot of continuation plays. It's been one day, breakouts and the gap ups almost always seem to fail right out of the gates. Matt, that's a point you noticed the other day.

It's like normally you buy it.

You just buy the app.

Now they all seem to fail right out of the gates. Matt, that's a point you noticed the other day is like normally you buy, you just buy the app. Now they all seem to dip out of the open, which is a really interesting thing. So that's something to keep in mind for the plays that we're going to be bringing up. Just trying to notice the patterns. Again, it doesn't mean everyone's going to do it, but we do have a hot OTC we're going to talk about today. So definitely.

Remember, this is not investment advice.

Yeah, so you brought up the gaps.

OTCs, if you have watched any previous education, it doesn't really matter from what trading guru,

you'll hear the red, green level, matters a lot.

And that's just the previous closed price. And something that

totally has not mattered for OTCs in 2020, pretty much has been that red green level. You'll see

...